FDA: Gout Drug Uloric Increases Risk of Death

FRIDAY, Feb. 22, 2019 -- The gout medicine Uloric (febuxostat) carries a higher risk of death than allopurinol, according to the U.S. Food and Drug Administration. The agency said its in-depth review of results from a safety clinical trial found...
Source: Drugs.com - Pharma News - Category: Pharmaceuticals Source Type: news